press releases

home > press releases

- 2011
- 2010
- 2009
- 2008
- 2007
- 2006
- Archives >>

Dec 19 Addex begins Phase IIa Proof of Concept Study on ADX10059 for Treatment of Acute Anxiety

Sep 19 Addex Pharmaceuticals Raises CHF40 million-SR One and Roche Venture Funds invest in Series C Private Financing

Aug 30 Addex commences Phase II clinical trials programme with ADX10059

home | contact | sitemap | impressum

© 2012, ADDEX Pharmaceuticals